A false-positive mammogram result leaves women anxious, but new research shows that the anxiety is short-lived and may have an unintended beneficial effect.
Vaginal atrophy doesn’t have to be a life sentence of painful sex. New research describes a solution for dyspareunia that can take sex from “painful” to “comfortable.”
The FDA has approved an HPV DNA test to be used as a primary screening method for cervical cancer in women 25 and older. The test can also give insight into future risk of cervical cancer.
The FDA has weighed in on the safety of uterine fibroid morcellation. Given the current evidence, find out what they recommend.
The safety of fertility drugs has been a concern to physicians and patients alike. A new study assessing fertility drugs and breast cancer risk has reassuring results.
Digital mammography is superior to screen-film mammography, and the digital technology has other patient benefits as well, a new study finds.
Mammography screening for breast cancer saves lives: this should be the message that physicians spread to colleagues and patients, say leading experts.
New research expected this year will bring about significant changes to clinical practice. Here, society leaders share what’s on their radar for 2014.
What research from the past year will have the most significant impact on women's health care? The leaders of five major ob/gyn societies weigh in.
Three doses of the quadrivalent HPV vaccine was more effective in preventing high-grade cervical abnormalities than other types and more effective in younger women.